UBC Named Preferred Oncology Research Partner
United BioSource Corp. has been named the preferred oncology research partner by RainTree Oncology Services Corp
United BioSource Corp. (UBC) has been named the preferred oncology research partner by RainTree Oncology Services Corp., a community oncology alliance. The alliance seeks to standardize research processes within the the RainTree community oncology setting, UBC will have access to patient data and will partner to administer prospective and retrospective observation studies, which will provide information about the safety and efficacy of medicine in daily clinical use. UBC is a subsidiary of Express Scripts.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
